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LITERATURE REVIEW

The monocyte-macrophage system is a network of specialized
phagocytic cells, including peripheral blood monocytes, Kupffer cells
of the liver, microglial cells of the brain, macrophages of lymph
node

and

spleen,

alveolar

macrophages and fluid

macrophages,

other

phase macrophages (13).

fixed

tissue

Macrophages playa

variety of roles in both the afferent and efferent limbs of the
immune response.

Macrophages are involved in the initiation of

immune reactions as antigen-presenting cells, and in the effector
phase as inflammatory, tumoricidal, microbiocidal and regulatory
cells (11 ,64).
originate

from

macrophages
Because

There is evidence that peripheral blood monocytes
bone
are

derived

macrophages

hypothesized

that

precursor cell
diversity

marrow

(49).

subpopulations

precursor

from

perform

it was

cells

circulating
many

unlikely

for

and

monocytes

functions,
a

that

single,

tissue
(22,48).

investigators
homogeneous

population to be responsible for such functional
Indeed,
exist

which

evidence
may

suggests

represent

that

monocyte

different

activation

states, different stages of maturation, or distinct, stable subsets
(12,21 ).

Evidence For Macrophage Heterogeneity

The

development of

monoclonal

antibodies

to

human

T

lymphocyte surface antigens allowed for the characterization of T
lymphocyte subsets (33).

The same approach has been used to study

1

2

antigenic

markers

on

the

surface

of

tissue

and

fluid

phase

macrophages and has revealed surface membrane heterogeneity
among macrophages from different anatomical sites (6).
Cell surface antigens have been identified that are present
virtually exclusively on human peripheral blood monocytes (5,29),
tissue or fluid phase macrophages (1-3,6,57,58,67).

In addition, cell

surface antigens have been identified that are present on peripheral
blood monocytes and tissue or fluid macrophages (29,63).

The PHM3

monoclonal antibody detects a surface antigen that is expressed by
most peripheral blood monocytes but is expressed only at very low
levels on peritoneal macrophages and Kupffer cells (5).
FMC17

and

FMC34

recognize

antigens

present

on

Likewise,
circulating

monocytes that are lost or markedly decreased in quantity when
monocytes enter inflammatory sites (29).
et

al.

described

antibodies

anti-PAM1

specific

for

lung

macrophages, respectively (6).

and

On the other hand, Biondi

anti-BMM1,

macrophages

two
and

monoclonal
breast

milk

Andreesen et al. described a series

of monoclonal reagants that recognize MAX antigens which are found
only on exudate macrophages residing in serous cavities (1-3), while
Dimitriu-Bona et al.
demonstrate

reported

moderate

on

and weak

M0P-15 and

M0P-7,

which

immunofluorescent staining,

respectively, for the majority of circulating monocytes but intense
staining for fluid phase macrophages (14).

Moreover, Zwadlo et al.

have shown that the monoclonal antibody 27F9 labels most resident
tissue macrophages but not circulating monocytes (67).

However,

PHM2, FMC32, FMC33, and 63D3 persist through all stages of

3
mononuclear

phagocyte

differentiation,

including

end-stage

granuloma formation (29,63).

Evidence For Monocyte Functional Heterogeneity

In

the

last ten

years,

numerous

studies

have

revealed

functional heterogeneity of human peripheral blood monocytes and
the

presence

functionally

of
and

subpopulations

which

morphologically

may

represent

both

different

subsets

(16,

19,21 ,25,32,39,44,45,47,56,61 ,62,66).
elutriation,

Percoll

and

bovine

Countercurrent centrifugal

serum

albumin

(BSA)

density

gradients, and adherence have been used to physically separate
monocytes into subpopulations.
Monocyte subpopulations differing in' Fe receptor activity have
been

isolated.

centrifugal

Norris

elutriation

and
to

coworkers,

isolate

using

monocyte

countercurrent
subpopulations,

demonstrated that peripheral blood monocytes could' be divided into
two subsets, which they designated "small" and "large" (45).

Both

subsets were phagocytic, glass adherent and nonspecific esterase
positive.

However, the small monocytes were deficient in

Fe

receptor-mediated activity, while the large monocytes were not.
This study was flawed, however, since it appears that there was
significant
fraction.

lymphocyte

contamination

of

the

small

monocyte

Melewicz and Spiegelberg, using adherence to isolate

monocytes from mononuclear cell preparations, presented evidence
that a subpopulation of monocytes from healthy human donors

4

presumably mediated phagocytosis and lysis of IgE-coated target
cells through their Fe receptors for Ig E (39).
Functional

heterogeneity with

factor (CSF) release has

respect to colony-stimulating

been shown.

Yasaka et al. isolated two

monocyte subpopulations by countercurrent centrifugal elutriation
(66).

The

two

subpopulations

exhibited

similar

functional

properties; however, the larger subpopulation was responsible for
greater CSF release.

Likewise,

Tice et aI.,

upon

separating

monocytes on Percoll gradients, found significantly greater CSF
activity in the more dense monocyte fractions than in the least
dense fraction

(56).

Because monocytes were isolated

from

mononuclear cells by one hour adherence in this study, it is possible
that

differential

activation

of

the

isolated

subsets

may

have

occurred, generating artifactual subpopulations.
Monocyte subpopulations differing in hydrogen peroxide (H202),
myeloperoxidase and tumoricidal activity have been isolated.

Turpin

et al. separated monocytes into subpopulations by countercurrent
centrifugal elutriation and showed that the large monocytes were
responsible for greater H202 production at day one of culture, while
by day three, small monocytes were the major producers of H2 0

2

(62).

Yasaka et al. found higher myeloperoxidase activity in the

larger

monocyte

elutriation (66).

fraction

isolated

by countercurrent centrifugal

Finally, Normann and Weiner separated monocytes

by elutriation and noted that only the small monocytes appeared
responsible for tumoricidal activity (44).
Differential

synthesis

of

prostaglandins

by

subpopulations has been reported by several invesigators.

monocyte
Goldyne

5
et al. sedimented human peripheral blood monocytes isolated by
adherence through a five step discontinuous BSA density gradient
and

found

significant differences

in

prostaglandin

E2

However, in this study the

synthesis among the subpopulations (25).

stimulus used for monocyte activation was not mentioned.
al.,

when

fractionating

(PGE2)

mononuclear

cell

Picker et

suspensions

on

discontinuous BSA gradients, showed that a population of low
density monocytes produced the majority of PGE (47).
Treves et al.

Finally,

isolated monocytes by adherence to plastic and

reported that the loosely adherent monocytes secreted more PGE2
than the strongly adherent ones (61).
Differential

interleukin-1

(IL-1)

elaboration

by

defined human monocyte subpopulations has been noted.

densityElias et al.

divided monocytes into subpopulations using discontinuous Percoll
density gradients (16).

The denser monocytes produced more IL-1

than the less dense cells.
blood

Khansari et .al. separated human peripheral

monocytes on discontinuous BSA gradients and

production

of the

majority of

monocyte fractions (32).
monocytes

secreted

PGE2 and IL-1

reported

by two different

Finally, Treves found that loosely adherent

higher amounts

of

IL-1

than

the

strongly

adherent monocytes (61).
Nichols et al. demonstrated differential specific activities of
P G E2 and thromboxane 82 (Tx82) released by lipopolysaccharide
(LPS)-treated

human monocytes over a 24 hour period, which

suggests the presence of at least two subpopulations of monocytes
with distinct secretory responses (42).
derived

from

a

common

precursor,

Because PGE2 and TxB2 are
arachidonic

acid,

in

the

6
cyclooxygenase pathway, one would have expected identical specific
activities for TxB2 and PGE2 if LPS-treated human monocytes were
labeled with arachidonic acid of uniform specific activity.

In this

study, monocytes were prelabeled for two hours with 0.1 JlCi/ml of
3H-arachidonic acid and 14C-arachidonic acid.

Cells were then

washed to remove unincorporated label and treated continuously
with 10 Jl9/ml Salmonella typhimurium
arachidonic acid.
to

determine

supernatants.

LPS plus 0.1 JlCi/ml 14C_

Parallel unlabeled cultures were treated with LPS

immunoreactive

PGE2 and TxB2 levels in culture

The specific activities of 3H- and 14C_ PG E2 during the

0-2 hour interval were similar and approximately three times higher

than the corresponding TxB2 specific activities.

By 24 hours, the

specific activities of 3H-PGE2 and 3H-TxB2 converged to a lower
level while the 14C_TxB2 specific activity increased to almost equal
that of 14C-PGE2.
In

addition,

this

study

attempted

to

examine

whether

differences in PGE 2 and TxB2 specific activities could be attributed
to

the

selective

conversion

of arachidonic acid

from

specific

sources, either free exogenous arachidonic acid or arachidonic acid
incorporated in membrane phospholipids.

Monocytes were pulse-

labeled for two hours with both 0.1 JlCi/ml 3H- and 14C-labeled
arachidonic acid.

Cells were then washed and treated continuously

with medium containing LPS and either 14C-arachidonic acid alone,
3H-arachidonic acid alone, or both 14C-arachidonic acid and 3Harachidonic acid' at 0.1 J,lCi/ml.

3H/ 14 C ratios for radiolabeled PGE2

and TxB2 in culture supernatants were intermediate between 3H/ 14 C
ratios

for

free

arachidonic acid

and

the

major

phospholipids

7

(phosphatidylinositol,

phosphatidylcholine

and

phosphatidyl-

ethanolamine) during the 0-2 and 2-8 hour time intervals regardless
of continuous label used.

These experiments showed that both

exogenous and endogenous sources of arachidonic acid serve as
sources of TxB2 and PGE2.

Therefore, the differences in metabolic

specific activities between PGE2 and TxB2 cannot be accounted for
by selective metabolism of either source of arachidonic acid (42).
Even though there is abundant evidence in the literature which
suggests that human peripheral blood monocytes may consist of
functionally different subsets, conclusive evidence is lacking for
several reasons.
isolate

human

First, several different techniques were used to
peripheral

blood

monocytes,

interpretation of the literature difficult.
adherence was

used to

Monocytes obtained
isolation procedure.

enrich

thereby

In a number of studies,

mononuclear cell

by adherence

making

are often

preparations.

activated by this

Second, detection of cell surface markers with

monoclonal antibodies was not used to rule out the presence
other

contaminating

peripheral

lymphocytes, in monocyte cultures.
isolated

by

blood

particularly

"Pure" monocyte preparations

adherence often contain plastic adherent, activated

lymphocytes or phagocytic granulocytes.
and stimuli

elements,

of

Third, culture conditions

used to activate the monocytes were not uniform.

Furthermore, no mention was made of monocyte secretory product
release from unstimulated monocyte cultures in a number of these
studies.

Finally, DNA assays to correct for cell number were not

performed in several of these investigations.

8
Evidence For Monocyte Phenotypic Heterogeneity

Monoclonal antibodies have been developed in an attempt to
define distinct monocyte populations.

Breard et al. used OKM1

(CD11 b), a monoclonal antibody to the C3bi receptor, to define two
populations of monocytes that differed with respect to cell size,
adherence properties and surface la antigens (9,53).

Shen et al. used

OKM1 and OKM5 to isolate two functionally distinct human monocyte
subsets (54).

These investigators identified a rosette negative,

OKM 1-, OKM5+ subset that triggered the autologous mixed lymphocyte
reaction, and a rosette negative, OKM1 +, OKMS- subset that could
only

minimally trigger this

reaction

expressed on greater than 90%
OKM5 is expressed on 75%

(54).

OKM1

is

of peripheral blood monocytes and

of peripheral blood monocytes, the results

of this study have been questioned (36).
OKM 1 is expressed by 30%

Because

Furthermore, because 1)

of peripheral blood lymphocytes and most

natural killer (NK) cells, neutrophils and eosinophils, and 2) OKM5 is
also reactive with platelets, the presence of other peripheral blood
elements in monocyte isolates could have had a great impact on the
observed results.
OKM3

and

OKM6

Finally, Talle et al. demonstrated reactions of
with

subsets

of

adherent

monocytes

(55).

Unfortunately, these antibodies have never become commercially
available and no additional reports on their characteristics have
appeared in the literature.
Raff et at. have reported that cells positive for Mac-120 and
HLA-DR can function in the genetically restricted presentation of
antigen to T cells, while cells negative for Mac-120 and positive for

9

HLA-DR cannot (50).
120

positive

autologous

In addition, this group demonstrated that Mac-

cells were the

mixed

most effective

lymphocyte reaction.

stimulators of the

However,

the

staining

pattern of Mac-120 does not reveal the prese.nce of subpopulations
(26),

and the monoclonal antibody and clone responsible for its

production are no longer available.

This antigen is not generally

accepted as a monocyte subpopulation marker.
Several groups over the last few years have identified cell
surface antigens that are expressed only in response to monocyte
activation by either LPS, phorbol esters, or muramyl dipeptide, a
structurally defined fragment of bacterial peptidoglycan (18,30,59).
Although these monoclonal antibodies have not yet been reported to
identify

a

subset

that

has

9.reater

functional

activity,

these

antibodies do serve as excellent markers of monocyte activation.
Todd et al. produced a monoclonal antibody, anti-M03e, whose
expression is increased by LPS (59).

A more detailed

this monoclonal antibody will follow.

description of

Furthermore, Ewan et al.

developed a monoclonal antibody, A1-3, which binds selectively to
LPS-stimulated human peripheral blood monocytes and is associated
with procoagulant activity (18). In an immunohistochemical study
using this antibody, Hancock et al. found restriction of A1-3 binding
to monocytes in inflammatory tissues and not in normal tissues
(30).

Similarly, Zwadlo et al. produced a monoclonal antibody,

27E10, that detects a surface antigen found only on macrophages in
inflammatory tissues and not in normal tissues, and detects an
antigen that is present on only 20%
(68).

of peripheral blood monocytes

27E10 antigen density is increased by stimulating monocytes

10
in culture with y-interferon

(IFN),

12-0-tetradecanoyl-phorbol-13-

acetate (TPA) and LPS.

Interestingly, Zwadlo et al. have also

described a surface antigen, RM3/1, that is down-regulated by LPS,
y-IFN,

and TPA and appears to be associated with the healing phase

of the inflammatory process (69).
At this time, however, no monoclonal antibody is uniformly
accepted as a marker of a distinct monocyte subpopulation.

Characteristics of Mo3e and Leu-M3

Freshly isolated adherent human monocytes express barely
detectable amounts of the M03e antigen on their cell surfaces (59).
However, following an 18-24 hour incubation at 37°e in RPMI 1640
medium containing E. coli LPS, monocytes demonstrate a significant
increase in surface M03e expressi.on (59).
monocytes cultured for the same duration

On the other hand,
in

LPS-free medium

express surface M03e levels comparable to those observed for
freshly isolated cells (59).
myristate

acetate

(PMA)

In addition, muramyl dipeptide, phorbol
and

other

biologically

compounds· cause a dose-dependent increase
expression

boy

monocytes cultured

containing these agents (59).

for

in

active

phorbol

surface

18-72 hours

in

M03e

medium

M03e has been termed an activation-

associated antigen because it is selectively expressed by activated
macrophages and monocytes.
expression.

However, y-IFN has no effect on M03e

The Mo3e antigen

is specific for

monocytes and

macrophages and it is identified by an IgM monoclonal antibody,
anti-M03e (35,59).

11

The Mo3e antigen is a protein determinant and is, therefore, a
protease-sensitive antigen (60).

Mo3e expression is temperature

dependent since

monocytes

incubation

of

at 4°C prevents its

expression, which suggests that Mo3e expression depends on active
cellular metabolism.

Furthermore, protein synthesis inhibitors such

as cycloheximide and puromycin block Mo3e expression by LPSstimulated monocytes.

Finally, pre-treatment of monocytes with

the anti-M03e antibody blocks their response to migration inhibitory
factor (MIF).

This effect is specific since other IgM monoclonal

reagants fail to block MIF activity (35).

These data suggest that

Mo3e is the MIF receptor (35).
The Leu-M3 antigen (CD 14) was first described by DimitriuBona et al. (14).
monoclonal

The

M~ P-9

antibody that

clone is responsible for the IgG2 b

recognizes

Leu-M3,

a pan-monocytic

marker that is present on 70-900/0 of human

peripheral blood

monocytes, 77-900/0 of pleural or peritoneal fluid phagocytic cells,
and 86-92%

of synovial mononuclear phagocytes (Becton-Dickinson

technical bulletin).

The Leu-M3 antigen is found at high densities on

monocyte and macrophage cell surfaces.

Leu-M3 is present at very

low antigen densities on a minimal fraction of peripheral blood
granulocytes

(14),

and

erythrocytes, or platelets.

does

not

react

with

lymphocytes,

RATIONALE AND SPECIFIC OBJECTIVES

The independent synthesis of TxB2 and PGE2 by counterflowisolated

human

subsets with

monocytes suggests the presence of monocyte

different secretory

responses

(42).

Furthermore,

although inconclusive, there are numerous papers in the literature
which suggest that monocyte subpopulations exist and differ with
respect to PGE2 and IL-1 p release, Fe receptor expression,
stimulating

activity,

H202

production

and

tumoricidal

colonycapacity

(16,25,32,44,45,47,56,61 ,62,66).
It was reported that peripheral blood monocytes from patients
with severe periodontitis secreted two to three times more PGE2 in
response to LPS from Bacteroides gingiva/is, B.

Actinobacillus

actinomycetemcomitans or Salmonella

intermedius,
typhimurium

than peripheral blood monocytes of sex-, age-, and plaque-matched
patients

without

secretion

of

attachment

IL-1 J3

patient groups.

loss

(24).

However,

monocyte

did not significantly differ between the two

A PGE2 hypersecretory response has also been

observed in peripheral blood monoctyes isolated from patients with
Hodgkin's disease when

compared

to

monocytes

isolated

from

healthy control patients (17,27).
Because monocyte subpopulations that differ with respect to
PG E2

release

hypersecretory

may exist, it is tempting to speculate that the
responses

observed

in

severe

periodontitis

and

Hodgkin's disease patients may be a result of hypersecretion of a
distinct subset.

In addition, the differential specific activities of

TxB2 and PGE2 may be a reflection of different secretory responses

12

13

from distinct monocyte subpopulations.

It is the purpose of this

thesis to assess PGE2, TxB2 and IL-1 ~ release from LPS-stimulated
monocyte subsets generated by either countercurrent centrifugal
elutriation

or

discontinuous

Percoll

density

centrifugation,

the

major methods that have been used in previous investigations to
fractionate
However,

peripheral
no

study

in

blood
the

monocytes
literature

into

has

subpopulations.

evaluated

monocyte

subpopulations generated by both methods and no investigation has
combined

the

Counterflow

two

techniques

centrifugal

to

generate

elutriation

was

monocyte
selected

subsets.

to

enrich

mononuclear cell preparations for monocytes because elutriation, as
opposed to adherence, does not activate monocytes and allows for
rapid

isolation

(20,28,37,52).
determine

if

of

peripheral

blood

monocytes

in

high

purity

In addition, Mo3e expression was examined to
differences

in

cell

surface

expression

of

this

activation antigen could be correlated with differences in functional
responses between subpopulations.

M03e expression was examined

relative to expression of Leu-M3, the pan-monocytic marker which
served as a positive control.

ABSTRACT

The

purpose

of

counterflow-isolated

this

human

investigation
peripheral

was

blood

to

separate

moncytes

into

subpopulations by either discontinuous Percoll density gradients or
countercurrent centrifugal elutriation and to assess PGE2, TxB2 and
IL-1 f3 release by each of the subsets in response to Salmonella

typhimurium

LPS.

In addition, surface antigen expression of Leu-

M3, a pan monocytic marker, and M03e, an LPS-associated antigen,
was examined to determine if M03e expression could be correlated
with differences in functional responses.
levels

in

culture

supernatants

PGE2, TxB2 and IL-1(3
were

determined

by

radioimmunoassay.
After DNA correction, PGE2, TxB2 and IL-1 J3 release did not
differ

significantly

between

LPS-stimulated

monocyte

fractions

isolated by either countercurrent centrifugal elutriation or Percoll
density centrifugation.

In addition, although the specific activities

of PGE2 and TxB2 differed throughout the 24 hour LPS treatment
period, the specific activities did not differ between counterflowisolated subpopulations.

Furthermore, Leu-M3 and M03e antigen

expression on the monocyte cell surface did not significantly differ
at 0, 8, or 24 hours between subpopulations isolated by either
separation technique.

These data suggest that human peripheral

blood monocyte subpopulations separated by physical means are not
heterogeneous with respect to PGE2, TxB2 and IL-1(3 release as has
been previously reported and that the different specific activities of
TxB 2 and PGE2 may be due to independent metabolism within a single

14

15

population

of

subpopulations.

cells

rather

than

by

different

monocyte

INTRODUCTION

Numerous investigators in the past decade have physically
separated human peripheral blood monocytes into subpopulations on
the basis of density or size in an attempt to determine whether
monocyte

subsets with

different functional

capabilities can

isolated.

Counterflow centrifugal elutriation

has been

be

used to

fractionate monocytes into subpopulations that differ in Fc receptor
activity (45), CSF release and myeloperoxidase activity (66), H202
production

(62)

and

tumoricidal

activity

(44).

Centrifugation

through discontinuous Percoll and BSA density gradients has yielded
fractions exhibiting differences in colony-stimulating activity (56),
PGE release (4,25,32,47) and IL-1

production (16,32).

Finally,

adherence to plastic or glass has been used to separate monocytes
into subpopulations and Treves et al. found that loosely adherent
monocytes secreted higher amounts of IL-1 than strongly adherent
monocytes (61).

However, a number of these studies have been

criticized because either significant lymphocyte contamination of
monocyte cultures existed, activation of monocytes by the isolation
technique occurred or DNA assays were not performed to correct for
cell number.
The capacity of unfractionated counterflow-isolated

human

peripheral blood monocytes to independently synthesize TxB2 and
P G E 2 when stimulated with bacterial LPS has been previously
demonstrated (42).

Independent metabolism was confirmed by

showing that TxB2 and PGE2 had different specific activities within
each time interval during a 24 hour culture period.

16

These data

17

suggest

that

distinct

monocyte

subpopulations

with

different

secretory responses may exist within an unfractionated isolate of
It is uncertain whether these differential specific activities

cells.

are due to the existence of physically separable monocyte subsets.
Indeed, such

monocyte functional

heterogeneity may reflect the

existence of discrete cell lineages, subsets representing different
activation states or maturation states (21) or distinct metabolic
processes within a single subset of cells.
Attempts

have

been

made

to

define

discrete

monocyte

subpopulations using monoclonal antibodies (9,50,54,55).

However,

conclusive evidence that subpopulations differ with respect to cell
surface antigen expression

is lacking.

Because elaboration of

inflammatory mediators by monocytes is dependent on activation of
these cells by LPS, Iymphokines, and other soluble factors, it was
important to

identify activation-associated antigenic determinants

on the monocyte cell surface.
associated

antigenic

determinants

(18,30,35,59,60) and may be
subsets

in

.Monoclonal antibodies to LPSare

important in

different stages of

activation.

now

available

identifying
Todd

et

monocyte
al.

have

characterized the Mo3e antigenic determinant and have found that
freshly isolated monocytes express barely detectable amounts of
M03e on their cell surfaces (35,59).

However, after a 24 hour

exposure to LPS, a significant increase in Mo3e expression is seen
relative to monocytes exposed to LPS-free medium.
It is the purpose of this present investigation to determine
whether physical separation of counterflow-isolated monocytes into
subpopulations by either discontinuous Percoll density gradients or
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countercurrent

centrifugal

distinct secretory responses.

elutriation

yields

subpopulations

with

PGE2, TxB2 and IL-1 ~ release by LPS-

treated human monocytes were assessed.

11-1 ~ production was

investigated because 1) recent evidence suggests that the release of
IL-1 and PGE2 from monocytes is interrelated (34) and 2) 90%

of the

IL-1 produced by LPS-stimulated human monocytes is IL-1 r3 (46). In
addition, Mo3e expression relative to the expression of Leu-M3, a
panmonocytic

marker that

served

as

a

positive

control,

was

examined to assess whether differences in surface Mo3e expression
among the subpopulations could be correlated with differences in
functional responses.

MATERIALS AND METHODS

Materials

[3H]Arachidonic acid (sp. act., 100 Ci/mmole), [3H]TxB2, and

[3H] PG E2 were obtained from New England Nuclear (Boston, MA).
Ficoll,

TxB2,

PGE2,

penicillin,

streptomycin,

4' ,6-diamidino-2-

phenyl-indole (DAPI), FITC-conjugated goat anti-mouse IgG, FITCconjugated goat anti-mouse IgM, mouse IgG 2 b (MOPC 141), and mouse
IgM (TEPC 183) were obtained from Sigma Chemical Co. (St. Louis,
MO).

Hypaque was obtained from Winthrop-Breon Laboratories

(NY,NY).

Fluoresceinated beads were obtained from Flow Cytometry

Standards Corporation.

Falcon plastic culture dishes (16 mm) were

obtained from Becton Dickinson Labware (Lincoln Park, NJ).

Anti-

PGE 2 and Anti-TxB2 were obtained from Advanced Magnetics, Inc.
(Cambridge, MA) and fetal bovine serum was obtained from Hyclone
Laboratories (Logan, UT).

The IL-1 f3

radioimmunoassay kit was

obtained from Cistron Biotechnology (Pine Brook, NJ).

LPH-K thin-

layer plates (10x20 cm, precoated 200 f.1 m, silica gel G) were
purchased from Whatman International LTO. (Maidstone, England).
Bacterial lipopolysaccharide (Salmonella typhimurium) was obtained
from

Difco

Laboratories

(Detroit,

MI)

and

anti-Leu-5b

(isotype

IgG2a), anti-Leu-12 (isotype IgG1) and anti-Leu-M3 (isotype Ig G2b)
were obtained from Becton-Dickinson (Mountain View, CAl.
Mo3e

(isotype

IgM) was kindly

provided

(University of Michigan School of Medicine).
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Cell

Isolation

Healthy random donors served as the sources of whole blood.
Subjects

who

had

taken

non-steroidal

anti-inflammatory

within the past week were excluded from the study.

drugs

Citrated fresh

human blood, obtained by venipuncture, was layered over FicollHypaque (1.077g/ml) (8) and sedimented at 400 x 9 (35 min., 10°C).
The

mononuclear leukocyte fraction was collected,

diluted and

washed in phosphate-buffered saline (PBS) containing 0.27 mM EDTA
(2x, 125 x g, 15 min., 10°C).

This fraction was then subjected to

counterflow centrifugation (Beckman J2-21

centrifuge with JE-6B

rotor, Palo Alto, CA) to remove lymphocytes and platelets and yield
a highly enriched monocyte population, as previously described (51).
Elutriation
counter,

was

monitored

Coulter

by

Electronics,

electronic counting «Coulter ZMHialeah,

Florida).

Following

counterflow isolation, monocytes were pelleted in PBS containing
1010 autologous plasma (200 x g, 15 min., 10°C).

Monocytes were

diluted in MCDB 104 medium (38) supplemented with 1% heatinactivated fetal bovine serum, 100 U/ml penicillin and 100 Jlg/m I
streptomycin, at a concentration of 10 6 cells/ml.
at 10 6 cells/well in 16 mm plastic wells.

Cells were plated

All incubations were

carried out at 37°C in a H20-saturated 5°1o C02 atmosphere.

After

two hours, the medium was exchanged to remove any nonadherent
cells.

At this time (time zero), 10 J.1g/ml of Salmonella typhimurium

LPS was added to half the wells.

The other wells served as controls.

Medium was removed at 2, 8, 16 and 24 hours and was replaced with
fresh identical medium, and the supernatants were collected and
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frozen.

For experiments evaluating labeled metabolite release,

labeled arachidonic acid (0.1 JlCi/ml) was added to culture medium
either during the two hour adherence period only for pulse-labeled
cultures or during the two hour adherence period and the 24 hour LPS
treatment period for continuously-labeled cultures.

Incubation of Nonadherent Monocytes

Some media samples removed at 0, 2, 8, and 16 hours were
transferred to different culture wells and incubated until the 24
hour

time

point.

These

supernatants

included

nonadherent

monocytes (cells that had detached from the plates) and eicosanoids
produced by adherent cells during either the 0-2, 2-8 or 8-16 hour
time

intervals.

This

additional

incubation

was

designed

to

determine the contribution of the nonadherent monocytes to overall
eicosanoid production.

Separation of Monocytes into Subpopulations

Fractionation of monocytes into subpopulations by elutriation
was achieved by varying the flow rate of the eluting buffer.

After

the lymphocytes were eluted (mean=11 ml/min) the flow rate was
increased (mean=13.8 ml/min) until the small monocytes began to
elute.

Once the small monocytes eluted, the superior portion of the

Sanderson chamber clarified and a new interface formed.

At this

time, the flow rate was once again increased (mean=15 ml/min)
until the intermediate-sized monocytes began to elute.

After these
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monocytes were collected, the remaining subpopulation was eluted
from the chamber by terminating centrifugation and flushing cells
from the rotor.
Fractionation

of

monocytes

into

subpopulations

by

discontinuous density centrifugation was achieved by layering the
whole counterflow-isolated monocyte preparations over 10, 40, 45
and 50%

Percoll (40, 45 and 50%

Percoll corresponded to specific

gravities of 1.048, 1.056, and 1.063 g/ml, respectively).
were made to use density gradients of 35 and 55%
too

few

cells

gradients.

were

isolated

from

the

Attempts

Percoll; however,

interfaces

with

these

Monocyte subpopulations were aspirated from density

interfaces and pelleted in PBS to remove any remaining Percoll (2x,
200 x g, 15 min., 4°C) prior to placing them into culture.

Radioimmunoassay for PGE 2 , TxB2 and IL-1 J3

Levels
determined

of
by

PGE2 and

in

radioimmunoassay

determined

by

culture
using

supernatants

were

immunoadsorption

to

Levels of IL-1 ~ in culture supernatants

dextran-coated charcoal.
were

TxB2

a

radioimmunoassay

which

utilized

a

polyethylene glycol second antibody to precipitate antibody-antigen
complexes

(according

to

Cistron

technical

bulletin).

All

determinations were carried out in d'uplicate and the average counts
for each pair were used to calculate PG E2, TxB2 and IL-1 J3 levels.
Regression
~

coefficients for logit-Iog-transformed standard curves

were generally greater than 0.990.
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Labeled

Arachidonic

Acid

Metabolite

Extraction

and

Separation

Arachidonic acid metabolites were extracted by adjustment of
the pH of culture supernatants to 3.5 with formic acid (70%)
followed by 3 3-ml washes with ethyl acetate.

The combined

organic extracts were evaporated to dryness under vacuum and
stored at -20°C under nitrogen.

Prior to thin-layer chromatography,

arachidonic acid (5 Jlg), PG E2 (5 f.1g) and TxB2 (5 f.1g) were added to
each sample and the contents were dried under a stream of nitrogen.
Individual samples were dissolved in 10 JlI of chloroform, mixed
vigorously, and spotted on silica gel G plates.

Three additional

washes with 5 J.11 of chloroform were then performed and each wash
was plated immediately below the previous application.

Plates were

then developed in one dimension with chloroform/methanol/acetic
acid/H 2 0 (90:8:1 :0.8, vol/vol) (65).

After drying, the plates were

sprayed with H20 and the lipid spots were visualized.
acid

Arachidonic

metabolites were identified by co-migration with

authentic

standards (Rf values were 0.80 for arachidonic acid, 0.512 for PGE2
and 0.40 for TxB2).

The plates were then scraped and counts

determined.

Determination of Cell DNA Content

DNA content of adherent monocytes was determined at 0, 8 and
24 hours.

Cells were treated with 0.5 ml of 5 mM NaOH and

sonicated briefly.

After a one week incubation with NaOH to insure
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~I

complete solubilization of the DNA, 1 00
assayed

for

from each well was

DNA content by the 4' ,6-diamidino-2-phenyl-indole

fluorometric assay of Brunk et al. (10).

Flow

Cytometric

One

Analysis

million monocytes

isolated

by

counterflow

centrifugal

elutriation or Percoll density centrifugation were placed into 12 X
75 mm siliconized glass test tubes.

At either 0, 8, or 24 hours, the

suspension was centrifuged at 200 x 9 (5 min., 4°C).

Saturating

doses of anti-Leu-M3 or anti-Mo3e were incubated with the pellet
(30 min., 4°C).

Following two washes with PBS containing 5 mM

EDTA, the test cells were incubated with fluorescein-conjugated
goat anti-mouse immunoglobin of the appropriate isotype in antibody
excess (30 minutes, 4°C).

The cells were then washed twice and

fixed in 100/0 buffered formalin.

Prior to FACS analysis, cells were

centrifuged at 200 x g (5 min., 4°C) and suspended in 0.5 ml
Hematall.

Ten thousand cells were examined by the FACS Analyzer

(Becton Dickinson, Mountain View, CAl and the channel number
representing the mean fluorescence intensity for each monoclonal
antibody was determined.

The FACS Analyzer was calibrated each

day with fluoresceinated beads and the photomultiplier tube setting
was

held constant for each

resonance).

Cell

experiment

viability was evaluated

exclusion and always exceeded 900/0.

(400

V at

maximum

by propidium

iodide

The extent of T and B

lymphocyte contamination was assessed with anti-Leu-5b and anti-
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Leu-12,

respectively.

The irrelevant monoclonal antibodies MOPC

141 (lgG 2 b) and TEPC 183 (lgM) served as negative controls.

Data

Analysis

Monocyte subpopulation means for PGE2, TxB2 and IL-1 p release
after DNA correction were compared by two-way ANOVA, with
treatment

and

fraction

as

the

independent

grouping-variables.

Monocyte subpopulation means for PGE2 and TxB2 specific activities
were compared by three-way ANOVA, with treatment, fraction and
time interval as the independent grouping-variables.

RESULTS

Distribution of Monocytes into Subpopulations

The mean distribution of monocytes isolated by discontinuous
Percoll density centrifugation was as follows:

Fraction 1, harvested

from the density interface between 10 and 40%
12%

of the cells,

while

Fraction

interface between 40 and 45%

2,

Percoll, contained

harvested at the density

Percoll, contained 30%

of the cells,

and Fraction 3, harvested at the density interface between 45 and
500/0 Percoll, contained 58%

large

monocytes

isolated

of the cells.

The small, medium, and

by counterflow

centrifugal

elutriation

represented 27, 31, and 42%, respectively, of all recovered monocyte
isolates from six donors.

Coulter
Isolated

Profiles

for

Percoll-Isolated

and

Counterflow-

Monocyte Subpopulations

Percoll fractionation resulted in a substantial separation of
monocytes by relative cell size (Figure 1).

The three subpopulations

isolated by elutriation differed markedly with respect to elution
properties, although their relative cell sizes were not as disparate
as monocyte fractions isolated by discontinuous Percoll gradients
(Figure 2).
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PG E2' TxB 2 and IL-1~ Production by Percoll Fractions

In general, PGE2 release from fractions 2 and 3 was similar for
all time intervals (Figure 3).

However, monocytes from fractions 2

and 3 secreted two to three times more PGE2 than monocytes from
fraction 1.

Even though the same number of monocytes was plated

initially for all fractions, fraction 1 cultures retained only half as
much DNA per well as fractions 2 and 3 when compared at 8 and 24
hou rs

(Table

1).

Two-way

ANOVA

revealed

no

statistically

significant difference between fractions for PGE2 release, after DNA
correction.
Similarly,

TxB2 release from fractions 2 and 3 was virtually

identical for all time intervals (Figure 4).

However, cells from

fraction 1 secreted two to four times less TxB2 than cells from the
other two fractions.

As for PGE2, TxB2 release after DNA correction

did not differ significantly between fractions when assessed by
two-way

ANOVA

(Table

1).

Furthermore,

all

three

fractions

exhibited the typical pattern of immunoreactive TxB2 release:

peak

release during the 2-8 hour interval followed by a diminution in
Tx B2

release at the 16-24 hour interval to levels below those

observed for the 0-2 hour interval.
The vast majority of IL-1 f3 release occurred during the 2-8
hour interval.

For this culture interval, 11-1 f3 release from fractions

2 and 3 was virtually identical.

However, IL-1 f3

Fraction 1 was two and one-half times less than
the other two fractions (Figure 5).

secretion

by

IL-1 f3 secretion by

After DNA correction, there was
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no

statistically

significant

difference

between

fractions

with

respect to IL-1J3 release (Table 1).
LPS-stimulated

eicosanoid

and

IL-1 J3

release was always

significantly greater than the control release of these mediators for
all fractions for all time intervals.

P G E 2, TxB2 and IL-1 (3 Production by Elutriator Fractions

P G E 2 release did not differ between fractions for any of the
time intervals (Figure 6).

In contrast to Percoll fractions, DNA

correction did not change this finding because the DNA remaining per
well at 24 hours was virtually identical for each fraction and for
both control and LPS':'stimulated cultures (Table 2).

In addition,

TxB 2 and IL-1 (3 release did not differ between fractions for each
time interval (Figures 7 and 8).

Likewise, DNA correction did not

alter these findings (Table 2).

Specific

Activities

Elutriator

of

PGE2

and TxB2 for

Pulse-Labeled

Fractions

The specific activity of PGE2 for the 0-2 hour time interval
was three and a half times higher than for TxB2 (Figures 9 and 10).
The specific activities of both PGE2 and TxB2 converged to a lower
level by the 16-24 hour interval, although PGE2 still maintained a
specific

activity

that

was

twofold

higher

than

that

of

TxB 2 .

However, even though TxB2 and PGE2 had different specific activities
throughout the 24 hour time course, the specific activities of PGE2
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and TxB2 did not differ between fractions.

Control values are not

included in Figures 9 and 10 because the amount of immunoreactive
eicosanoid produced by monocytes not exposed to LPS was so low
that specific activity calculations were not meaningful.

Specific

Activities

Labeled

Elutriator

PGE2 and TxB2

of

for

Continuously-

Fractions

PG E2 had a specific activity that was four and

a

quarter times

greater than that of TxB2 during the 0-2 hour interval (Figure 11 and

12).

However, during the 24 hour time course, the specific activity

of PGE2 fell while the specific activity of TxB2 rose so that by the

16-24 hour time interval, the specific activity of TxB2
overtook that of PGE2.

actually

Once again, the specific activities of both

TxB2 and PGE2 did not differ between fractions for any of the time
intervals.

Leu-M3 and M03e Expression on Percoll-Isolated Monocyte
Subpopulations

A representative dot plot and FACS profiles are illustrated in
Figure 13.

M03e and Leu-M3 expression did not differ significantly

between fractions at 24 hours (Table 3).

Mo3e expression on the cell

surface of the third Percoll fraction (the smallest monocytes) was
27%

less than Mo3e expression on the cell surface of the first

Percoll

fraction

fluorescence

(the

intensity

largest monocytes).
for

M03e

was

Although

highest

for

the
the

mean
largest
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monocytes,

it

is

likely that relative

Mo3e

antigen

density

is

comparable between fractions because the largest cells also have
the greatest cell surface area.

Leu-M3

and

M03e

Expression

on

Counterflow-Isolated

Monocyte SUbpopulations

Mo3e antigen expression on counter-flow-isolated monocyte
subpopulations was not detectable at time zero, since
fluorescence

intensity

was

virtually

the

same

as

its mean
the

fluorescence intensity of the negative control antibody.

mean

However,

after an 8 hour exposure to LPS, Mo3e antigen expression was
significantly increased (Table 4).

A twofold increase in mean

fluorescence

intensity

between

Nevertheless,

no differences between

was

seen

8

and

fractions with

24

hours.

respect to

mean fluorescence intensity were observed for any of the time
intervals.

Greater than 800/0 of the monocytes were positive for the

Mo3e antigen at 8 hours and greater than 90%

of the monocytes were

positive for Mo3e at 24 hours.
Leu-M3 antigen expression on counterflow-isolated monocyte
subpopulations also did not differ between fractions (Table 5).
mean

fluorescence

intensity

for

the

Leu-M3

antigen

The

actually

diminished at 8 hours for all three fractions but increased by 24
hours to levels that were 68%

higher than at 0 hours.

DISCUSSION

In contrast to previous reports (16,25,32,47,56,61), this study
demonstrated that Percoll-isolated and counterflow-isolated human
peripheral blood monocyte subpopulations do not differ with respect
to PGE2, TXB2 and IL-1 ~ release.

It is likely that our findings differ

from those results previously reported for three reasons.

First,

counterflow centrifugal elutriation, which allows rapid isolation of
human peripheral blood monocytes in high purity, was used rather
than adherence to enrich mononuclear cell preparations.
indirect

immunofluorescence

confirmed

negligible

contamination of our monocyte preparations
w~re

performed to correct for cell

Second,

lymphocyte

Finally, DNA assays

number.

This

paper also

represents the first report in the literature to examine relative
antigen expression of monocyte markers on different subpopulations;
Leu-M3 and Mo3e antigen expression did not differ between subsets
isolated

by either Percoll density centrifugation

centrifugal

or counterflow

elutriation.

Monocyte purity was confirmed by showing that 70-900/0 of
counterflow-isolated monocytes expressed the Leu-M3 antigen and
that

negligible

numbers of cells

expressed

Leu-12 or Leu-5b.

Microscopic examination of cells using Wright's stain revealed the
absence of polymorphonuclear leukocytes and eosinophils in culture
wells.
was

Minimal platelet contamination of the monocyte preparations
observed

by

phase

contrast

microscopy.

It

has

been

demonstrated that PGE2 and TxB2 release from monocytes incubated
with a tenfold excess of platelets is comparable in control and LPS-
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stimulated cultures (42).

In addition, PGE2 and TxB2 release from

monocytes cultured with this excess of platelets is maximal during
the 8-16 hour time interval, rather than the 2-8 hour time interval.
Had there been substantial platelet contamination of the monocyte
cultures,

this

nonspecific

elevation

and

different

pattern

of

eicosanoid release would have been observed (42).
The anti-PGE2 antibody demonstrates 100 %
with PGE1, 90/0 with 15-HETE, 6%
P G F 2,

and

less

eicosanoids at 50%

than

1%

cross-reactivity

with PGA2, 3% with PGA1, 1.3% with
cross-reactivity

bound/total (42).

with

other

related

However, it has been shown

using gas chromatography-mass spectroscopy that 970/0 of PGE
production by human monocytes in response to bacterial LPS is PGE2
(25, 42).

In addition, LPS-treated monocytes release relatively

small amounts of eicosanoid products capable of cross-reacting in
the

PGE

radioimmunoassay (41).

Furthermore,

the

antibody demonstrates no significant cross-reactivity
0.1 %) with any of the aforementioned products.

anti-TxB2
(less than

Finally, the IL-1 p

antiserum used in the IL-1 ~ radioimmunoassay is specific for IL-1 p
and exhibits no cross-reactivity with
(Cistron technical bulletin).

IL-1 a, IL-2, TNF or 1-1 F N

Therefore, based on this information,

the PGE, TxB2 and IL-1 p radioimmunoassays

were

considered

acceptable to quantitate the release of immunoreactive PGE2, TxB2
and IL-1 (3.
The use of Percoll density centrifugation resulted in reduced
cell yield and higher control eicosanoid release when compared to
the elutriator fractions.

Because the cell yield was limited, DNA

corrections at 8 hours and determinations of mean fluorescence
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intensity at 0 and 8 hours could
experiment.

not be determined

in every

However, for those experiments when there was enough

cellular material, the ratio of DNA remaining between fractions 2 or
3 and fraction 1 at 8 hours was virtually th.e same as the ratio at 24
hours.

In addition, the mean fluorescence intensity did not differ

significantly between fractions at eight hours and monocytes from
all three fractions expressed

barely detectable levels of the M03e

antigen at time zero.
Previous studies (16,25,56) have demonstrated that higher
density monocytes produce greater amounts of PGE2 and IL-1.

Our

lowest density fraction corresponded to the same specific gravity
and represented the same percentage of total monocytes as the
lowest density fraction described by Tice et al. (56).

However,

because Fraction 1 never entered the gradient and only half as much
DNA was retained in its culture wells at 24 hours than in the other
two fractions, it is· likely that this fraction represented a damaged
cell popu lation.

Furthermore, the nonadherent cells (cells which

were not retained in the culture wells), although positive for LeuM3, did not produce appreciable amounts of TxB2, PGE2, or IL-1 ~ at
any time point.
Consistent with previous reports,

M03e expression on the

monocyte cell surface was significantly increased with exposure to
LPS for both Percoll-isolated and counterflow-isolated subsets (35,
59).

Indeed, M03e was not expressed on the cell surface at 0 hours

and an increase in its expression was seen after an 8 and 24 hour
exposure to LPS for all subsets, although monocytes in LPS-free
medium

for

24

hours did

not demonstrate cell

surface

Mo3e
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expression.

Mo3e antigen expression was even higher after 48 and

72 hours of LPS exposure; however, PGE2 and TxB2 release between
24 and 72 hours in culture was not significantly higher than control
levels (23).

Leu-M3 expression also increased

after a 24 hour

exposure to LPS, although there was actually a diminution in mean
fluorescence

intensity at 8 hours, which suggests shedding or

internalization of the Leu-M3 antigen between 0 and 8 hours.
Although
between

both

a

Leu-M3 and

and 24 hours, no

M03e expression

differed markedly

significant differences in Leu-M3 or

Mo3e expression were observed between subpopulations isolated by
either

Percoll

density centrifugation

or counterflow

centrifug"al

elutriation at any time point.
This study reveals no human monocyte subpopulation primarily
responsible for PGE2, TxB2 or IL-1{3 release.
may

exist,

but

mea~s

current

of

Such subpopulations

separating

monocytes

into

subpopulations based on density and/or size did not allow for subset
detection.

Our inability to define distinct monocyte subpopulations

is in agreement with a recent study by Dransfield at al. (15).
However,

the

results

of

this

experiment

suggest

that

the

independent synthesis of TxB2 and PGE2 observed in our laboratory
may

be

due

to

distinct

metabolic

processes

within

a

single

population of monocytes and not due to the existence of discrete
subpopulations.

Differential relea'se of immunoreactive TxB2 and

PG E2 could result from independent activities of the thromboxane
synthetase and prostaglandin isomerase enzymes, but the disparate
-

specific activities cannot

be explained in this way.

Differentially

labeled arachidonic acid pools and independent cyclooxygenase
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metabolic compartments within a single subset of cells may be
responsible for the differential specific activities of TxB2 and PGE2
released

from

divergent

LPS-activated

specific

chromatography-mass

monocytes.

activities

of

Confirmation

PGE2

spectroscopy

and

and

TxB2

exploration

of the
by gas
of

the

possibility of independent cyclooxygenase metabolic compartments
will be the focus of future studies.

Finally, the data in this study

suggest that the PGE2 hypersecretory response observed in patients
with

severe

periodontitis

(24)

and

in

disease (17,27) may reflect hypersecretion

patients with

Hodgkin's

of the entire monocyte

population rather than only a particular subset.

THESIS DISCUSSION

This

investigation

counterflow-isolated

demonstrated

that

Percoll-isolated

and

monocyte subpopulations do not differ with

respect to PGE2, TxB2 and IL-1 ~ release or Leu-M3 and Mo3e surface
antigen expression.

In the majority of previous studies, adherence

was used to enrich mononuclear cell preparations for monocytes.

It

is possible that this isolation technique coupled with the physical
removal of monocytes from plastic culture wells prior to assessing
functional activity activated the whole monocyte population, and
possibly some monocytes more than others.

This phenomenon is

likely since some monocytes are more adherent and, therefore, may
be activated by the scraping procedure to a greater extent than less
adherent

monocytes.

Furthermore,

in

each

of these

studies,

monocyte purity was assessed by nonspecific esterase staining,
morphology or phagocytosis of latex particles.
was

not

used

to

confirm

minimal

Immunofluorescence

contamination

of

monocyte

cultures with lymphocytes and other peripheral blood elements and
immunofluorescence was not used to confirm monocyte identity.
However, a number of these studies were conducted before the
availability of Leu-M3 and other monoclonal reagants that could have
confirmed

monocyte purity.

elutriation

was

used

in

Because countercurrent centrifugal

our

experimental

protocol

to

enrich

mononuclear cell preparations for monocytes and the elutriation
process was monitored by electronic sizing, the cells placed in
culture in this study were virtually all monocytes.

In previous

investigations, monocytes were cultured in RPMI 1640 medium at
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37°C for one hour with, in all likelihood, a fourfold excess of
lymphocytes.
played

a

Lymphokines elaborated by the lymphocytes may have
role

Interestingly,

in

in

the

the

activation

majority

of

of

monocytes

previous

in

culture.

investigations,

the

functional properties of monocytes in unstimulated cultures were
not mentioned.
The differential specific activities of PGE2 and TxB2 may be
accounted for by compartmentalization of cyclooxygenase enzymes
and

differentially

labeled

arachidonic

acid

pools.

However,

compartmentalization of cyclooxygenase enzymes has never been
demonstrated.

The PGE2 and TxB2 specific activity differences will

first be confirmed by gas chromatography-mass spectroscopy (GCMS) before exploring this possibility, since GC-MS represents the
best method

for specific estimation

of nanogram quantities of

prostanoids in the presence of interfering substances.
The patterns of immunoreactive TxB2 and IL-1 J3 release are
similar over the 24 hour time course.

In addition, between 24 and

72 hours, their release continues to decline and actually equals
control levels.

However, although peak release for PGE2 also occurs

during the 2-8 hour interval, another rise in PGE2 release occurs
during the 16-24 hour interval following a decline between 8 and 16
hours.
through

It has been shown that IL-1 can regulate its own production
PGE2, a self-induced inhibitor (34). IL-1 alone can elevate

endogenous PGE2 levels and the dose-dependent suppressive effect
of

exogenous PGE2 on IL-1 production by LPS-stimulated monocytes

has been demonstrated (34).

These phenomena may be responsible
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for the dimunition in IL-1 ~ release after 8 hours and the increase in
PG E2 release during the 16-24 hour interval.
Percoll and countercurrent centrifugal elutriation are accepted
techniques for separating monocytes into subpopulations, although
such separation may be artifactual.

This investigation represents

the first report in which both techniques were used to fractionate
monocytes into subpopulations and in which elutriation was used to
isolate monocytes from mononuclear cells prior to Percoll density
Even though both techniques resulted in monocyte

centrifugation.

subpopulations that differed with respect to relative cell size, no
functional or phenotypic heterogeneity was noted between subsets.
Cell sorting on the basis of cell size and shape may represent
another technique that can be used to evaluate potential monocyte
heterogeneity, but this method has several limitations that may
preclude its implementation.

First, 10-900/0 of the counterflow-

isolated monocytes may be lost during cell sorting (31).
monocytes may be activated by this technique.
sorter

can

only

process

10 7

cells

Second,

Third, since the cell

per hour,

it would take

approximately five hours to sort an average donor's monocytes (31).
Cells

isolated

at one hour may differ functionally from

those

isolated at the termination of cell sorting, merely because of the
long isolation procedure.
It

has

been

noted

that

inter-individual

differences

with

respect to PGE2 secretion by LPS-stimulated human monocytes far
exceed the intra-individual differences observed for replicate blood
donations up to six months apart (40, 43).

This phenomenon needs to

be explored more carefully, particularly since it appears that high
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and low responders to LPS may exist, using PGE2 release as the
marker of LPS-responsiveness (17,24).
worthwhile

to

investigate

relative

In addition, it would be
expression

of

activation-

associated antigens on the cell surface of human peripheral blood
monocytes in different donors to determine if 1) differences exist
between healthy individuals and 2) immunophenotypes remain stable
over time.

It has been reported that immunophenotypes of healthy

individuals examined on a weekly basis for 13 weeks differed less
than 5%

between donations with respect to

T4 and T8 antigen

expression (7).
Heterogeneity certainly exists among fluid macrophages.

The

multitude of functions that these macrophages perform coupled with
the evidence for restriction of cell surface markers to macrophages
of defined anatomical locations confirms this fact.

Whether or not

such heterogeneity is evident in human peripheral blood monocytes
is still uncertain.

Although our investigation did not reveal any

differences between subpopulations with respect to PGE2, TxB2
I L-1

f3

release,

numerous other monocyte functions

such

as

0

r

Fe

receptor-mediated activity, la expression, and phagocytosis need to
be re-examined

using counterflow-isolated monocytes, to assess

whether these functional activities differ among subpopulations or
whether previous investigations yielded artifactual differences.
addition,

further

studies

should

be

carried

out

to

In

compare

expression of differentiation antigens on bone marrow precursors,
blood monocytes and tissue and fluid phase macrophages.

Hancock at

al. have already shown that PHM3 labels a differentiation antigen
expressed on monocytes only after entry into the circulation (29).
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This

antigen

appears

to

be

restricted

in

its

distribution

to

circulating monocytes, as it is present only at very low antigen
densities on peritoneal macrophages and Kupffer cells.

Furthermore,

FMC17 appears to be organ selective since its expression is confined
to alveolar macrophages (29).

Relationships between bone marrow

precursor cells, monocytes, macrophages and other hematopoietic
elements

can

characterize

only

the

cell

be

elucidated

surface

mononuclear phagocyte system.

by

further

differentiation

studies

antigens

which
of

the

In addition, studies which correlate

functional activities that are restricted to certain tissue sites or
fluids with the presence of particular cell surface antigens will
enable

investigators

to

determine

whether

peripheral

blood

monocytes are a homogeneous, multipotent population or whether
discrete

monocyte subsets exist with predetermined capabilities to

differentiate into specific tissue or fluid macrophages.

Table 1.

PG E2, TxB2 and IL-1 ~ Release from Percoll-Isolated
Monocyte Fractions After DNA Correction

f3

Fraction #

PG E2

TxB2

IL-1

1 (Control)

0.25

O.12±O.11

O.O1±O.O1

1 (LPS)

O.32±O.O7

O.95±O.30

O.O2±O.01

2 (Control)

0.O4±O.O4

O.O6±O.O4

0

2 (LPS)

O.47±O.12

1.32±O.38

O.O4±O.O2

3 (Control)

O.O6±O.O5

O.12±O.O8

O.O1±O.O1

3 (LPS)

O.60±O.22

1.25±O.33

O.O5±O.O4

All values for PGE2 and TxB2 represent the mean (ng eicosanoid/Jlg
DNA) ±. standard error for the 16-24 hour time interval for six
determinations except
PGE2 for fraction 1 control, which only
represents one determination, ~ince the control release from the
other culture wells was zero.
All values for IL-1 J3 represent the
mean ±. standard error for three determinations
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Table 2.

PG E2, TxB2 and IL-1 ~ Release from Counterflow-Isolated
Monocyte Fractions After DNA Correction

Fraction #

PG E2

TxB2

IL-1 ~

Small (Control)

0

0

0

Small (LPS)

0.48±0.18

0.70±O.14

O.O8±O.O6

Medium (Control) 0

0

0

Medium (LPS)

0.45+0.15

O.70±0.17

O.O7±0.O7

Large (Control)

0

0

0

Large (LPS)

O.49±O.25

0.71±O.22

O.O4±O.O2

All values for PG E2 and TxB2 represent the mean (ng eicosanoid/J.lg
DNA) ±. standard error for the 16-24 hour time interval for six
determinations. All values for IL-1 ~ represent the mean ± standard
error for three determinations
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Table 3.

FRACTION

Leu-M3 and Me3e Antigen Expression on Percoll-Isolated
Monocyte Subpepulations at 24 Hours
Leu-M3

Mo3e

Fi rst

324.96±.71.52

398.39±11 .1 a

Second

293.44:±.20.55

351.26±.34.16

Third

348.48

289.83±45.62

All values represent the mean fluorescence intensity ±. standard
error for monocytes isolated from three different donors except for
Leu-M3 expression on the third fraction which represents one
determination.
The mean fluorescence intensity for the irrelevant
IgG2b murine monoclonal antibody (MOPC 141) was 18.43, while the
mean fluorescence intensity for the irrelevant IgM murine
monoclonal antibody (TEPC 183) was 15.45.
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Table 4.

Mo3e Antigen Expression on Counterflow-Isolated
Monocyte Subpopulations

FRACTION

QHOUR

Small

16.26±.3.18

136.88±10.88

261.21±13.42

Medium

16.62±.3.15

141.69±15.62

275.30±22.25

Large

17.42±.3.29

142.20±.25.70

285.54±.40 .89

8 HOUR

24 HOUR

All values represent the mean fluorescence intensity ±. standard
error for monocytes isolated from three diferent donors.
The mean
fluorescence intensity for the irrelevant IgM murine monoclonal
antibody (TEPC 183) was 10.19.
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Table 5.

Leu-M3 Antigen Expression on Counterflow-Isolated
Monocyte Subpopulations

FRACTION

OHQUR

8HQUR

24 HOUR

Small

137.07±8.76

100.98±12.97

225.75±12.14

Medium

133.81±5.85

96.74±11.79

232.61±17.48

Large

139.41±4.80

99.85±11.50

230.95±18.15

All values represent the mean fluorescence intensity ±. standard
error for monocytes isolated from three different donors.
The
mean fluorescence intensity for the irrelevant IgG2b murine
monoclonal antibody (MOPC 141) was 22.40.

Figure 1.
Fraction 1 represents the monocyte subpopulation
harvested at the density interface between 10 and 40% Percoll,
Fraction 2 represents the monocyte subpopulation obtained from the
density interface between 40 and 45% Percoll, and Fraction 3
represents the monocyte subpopulation harvested at the density
interface between 45 and 50% Percoll.
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Figure 2. Fraction 1 represents the first monocyte subpopulation
(small monocytes) to elute from the Sanderson chamber. Fractio.n 2
represents the second monocyte subpopulation to elute (mediumsized monocytes).
Fraction 3 represents the last monocyte
subpopulation to elute (large monocytes) after turning off the rotor.
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Figure 3. Time course of PGE2 release from human peripheral blood
monocytes that were fractionated into subpopulations by
discontinuous Percoll density gradients.
Monocytes were cultured
with either control medium or LPS-containing medium (10 JJ,g/m I
Salmonella typhimurium LPS). All values represent the mean ±
standard error for PGE2 release from six different donors.
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Figure 4. Time course of TxB2 release from human peripheral blood
monocytes that were fractionated into subpopulations by
discontinuous Percell d~nsity gradients.
Menecytes were cultured
with either control medium or LPS-containing medium (10 J,!g/m I
Salmonella typhimurium LPS). All values represent the mean ±.
standard error for TxB2 release from six different donors.
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Figure 5. Time course of IL-1 ~ release from human peripheral blood
monocytes that were fractionated into subpopulations by
discontinuous Percoll density gradients.
Monocytes were cultured
with either control medium or LPS-containing medium (10 Jlg/m I
Salmonella typhimurium LPS). All values represent the mean ±.
standard error for IL-1 f3 release from three different donors.
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Figure 6. Time course of PGE2 release from human peripheral blood
monocytes that were fractionated into subpopulations by
counterflow centrifugal elutriation.
Monocytes were cultured with
either control medium or LPS-containing medium (1 0 IJ,g / m I
Salmonella typhimurium LPS). All values represent the mean +
standard error for PGE2 release from six different donors.
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Figure 7. Time course of TxB 2 release from human peripheral blood
monocytes that were fractionated into subpopulations by
counterflow centrifugal elutriation.
Monocytes were cultured with
either control medium or LPS-containing medium (1 0 Jlg / m I
Salmonella typhimurium
LPS). All values represent the mean ±.
standard error for TxB2 release from six different donors.
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Figure 8. Time course of IL-1 ~ release from human peripheral blood
monocytes that were fractionated into subpopulations by
counterflow centrifugal elutriation.
Monocytes were cultured with
either control medium or LPS-containing medium (10 Ilg / m I
Salmonella typhimurium LPS). All values represent the mean +
standard error for IL-1 ~ release from three different donors.
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Figure 9. Time course of [3H] PG E2 release from LPS-treated human
monocytes fractionated into subpopulations by countercurrent
centrifugal elutriation.
Monocytes were cultured with medium
containing 0.1 ~Ci/ml [3H]arachidonic acid for two hours during the
period of cell adherence after which the cells were washed twice
with unlabeled medium.
Monocytes were then cultured in LPScontaining medium (1 0 JJ.g/ml Salmonella typhimurium LPS) for 24
hours without label, with media exchanges at 2, 8, 16 and 24 hours.
Each determination represents labeled eicosanoid extracted from
replicate (four) pooled culture supernatants.
Histogram bars
represent the mean ± standard error for [3H] PG E2 release from three
different donors.
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Figure 10. Time course of [3H]TxB2 release from LPS-treated human
monocytes fractionated into subpopulations by countercurrent
centrifugal elutriation.
Monocytes were cultured with medium
containing 0.1 JlCi/ml [3H]arachidonic acid for two hours during the
period of cell adherence after which the cells were washed twice
with unlabeled medium.
Monocytes were then cultured in LPScontaining medium (1 0 Jlg/ml Salmonella typhimurium LPS) for 24
hours without label, with media exchanges at 2, 8, 16 and 24 hours.
Each determination represents labeled eicosanoid extracted from
replicate (four) pooled culture supernatants.
Histogram bars
represent the mean ±. standard error for [3H]TxB2 release from three
different donors.
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Figure 11. Time course of [3H] PG E2 release from LPS-treated human
monocytes fractionated into subpopulations by countercurrent
centrifugal elutriation.
Monocytes were cultured with medium
containing 0.1 JlCi/ml [3H]arachidonic acid during the two hour cell
adherence period.
Monocytes were washed twice with unlabeled
medium and then treated with 10 J.1g/ml Salmonella typhimurium
LPS plus 0.1 JlCi/ml [3H]arachidonic acid.
Medium was exchanged at
2, 8, 16, and 24 hours and replaced with identical medium. Each
determination represents labeled eicosanoid extracted from
replicate (four) pooled culture supernatants.
Histogram bars
represent the mean ± standard error for [3H] PG E2 release from three
different donors.
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Figure 12. Time course of [3H]TxB2 release from LPS-treated human
monocytes fractionated into subpopulations by countercurrent
centrifugal elutriation. Monocytes were cultured with medium
containing 0.1 JlCi/ml [3H]arachidonic acid during the two hour cell
adherence period.
Monocytes were washed twice with unlabeled
medium and then treated with 10 J.19/ml Salmonella typhimurium
LPS plus 0.1 J.lCi/ml [3H]arachidonic acid. Medium ·was exchanged at
2, 8, 16, and 24 hours and replaced with identical' medium. Each
determination represents labeled eicosanoid extracted from
replicate (four) pooled culture supernatants.
Histogram bars
represent the mean ± standard error for [3H]TxB2 release from three
different donors.

69

Specific Activities of TxB from Continuously-Labeled Elutriator Fractions
2

II
Fa

2000

m

Small, LPS
Medium, LPS
Large, LPS

1500

cpmlng
1000

500

o
0-2 h

2-8 h

Interval

8-16 h

16-24 h

70

Figure 13.

Light-Scattering and FACS Profiles of Monocyte
Preparations (a, b, c)

(a) Representative light-scattering profile of a
subpopulation isolated by Percoll density centrifugation.

monocyte

(b) Representative FACS profile of a Percoll-isolated monocyte
subpopulation stained with a negative control IgM monoclonal
antibody by indirect immunofluorescence after a 24 hour incubation
with Salmonella typhimurium LPS (10 Jlg/ml).
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(c)
Representative FACS profile of a Percoll-isolated monocyte
subpopulation
stained
with
anti-Mo3e
by
indirect
.immunofluorescence after a 24 hour incubation with Salmonella
typhimurium LPS (10 )lg/ml).
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